News

Search:

FDA Gets Permanent Director for Reorganized Surveillance 'Super Office'

0 Likes

The US Food and Drug Administration (FDA) has announced the promotion of Gerald Dal Pan, MD to the position of permanent director of FDA’s Office of Surveillance and Epidemiology (OSE), where Dal Pan Read More...

Tags:

CDER

Dal Pan

Director

FDA

Office of Surveillance and Epidemiology

OSE

Promotion

Woodcock

Post-FDAAA, Regulators Move to Adapt to Changing Risk Models

0 Likes

With all the attention given to the US Food and Drug Administration’s (FDA) approval process, it can sometimes be easy to forget an equal amount of its time is spent on postmarketing issues related, Read More...

Tags:

Adverse Events

AERS

CDER

Dal Pan

drug

FDA

FDAAA

OSE

Pharmaceutical

Postmarketing

REMS

Surveillance

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

China's SFDA Becomes CFDA amidst Consolidation of Power and New Leadership 25 March 2013
FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

FDA Gets Permanent Director for Reorganized Surveillance 'Super Office'

Post-FDAAA, Regulators Move to Adapt to Changing Risk Models

Get RF Today